Strategic question
Where are our regional competitors investing in Digital Health, and should we follow or differentiate?
How Galen Growth helped
From market signal to decision-ready evidence
Using HealthTech Alpha, we reviewed competitor partnerships and investments across four markets, built a heat-map by therapeutic area and cluster, and classified competitor activity as Optimal, Misaligned, Risky or Re-think based on venture maturity and strategic fit.
Outcomes
Gave the client a structured, comparative read on competitive threat and strategic opportunity across the region.
Decision enabled: Enabled leadership to adopt a defensible follow-or-differentiate stance by market and therapeutic area.
Key results
Our approach
A repeatable path to a defensible decision
Define
Clarify the strategic question, decision owner, market boundaries, and success criteria.
Map
Identify the relevant ventures, markets, competitors, partnerships, and evidence signals.
Assess
Evaluate maturity, traction, clinical relevance, commercial fit, and operational readiness.
Decide
Translate the evidence into a shortlist, benchmark, market view, or portfolio recommendation.
Related work
More digital health case studies
Sourcing OMICS Ventures to Shape Oncology and Wellness Strategy
Which OMICS-led ventures tackling oncology and wellness are mature enough to partner with an enterprise insurer?
Sourcing HealthTech Ventures to Power Non-Fluid Underwriting
Which ventures across digital biomarkers, DTx, genomics and teleconsultation are mature enough to enable non-fluid underwriting?
Pressure-Testing a Digital Health Partnership Before Commitment
How does our preferred venture partner compare against credible alternatives in the same market and therapeutic focus?